Cannabinoid-based drugs as anti-inflammatory therapeutics.
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Cannabinoids in health and diseaseCannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammationBeta-caryophyllene is a dietary cannabinoidThe endocannabinoid system as an emerging target of pharmacotherapyThe CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetNovel cannabinoid receptorsPotential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's DiseaseEndocannabinoids in neuroendopsychology: multiphasic control of mitochondrial functionCannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005-2010.Interaction between Cannabinoid System and Toll-Like Receptors Controls InflammationCB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune DysregulationPharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndromeCannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's DiseaseAlkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsCannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated ratsEffects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signallingEmerging therapeutic targets of sepsis-associated acute kidney injury.Frontiers in pruritus research: scratching the brain for more effective itch therapyCannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoidsPursuing paradoxical proconvulsant prophylaxis for epileptogenesisProlonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisCB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.A population-based case-control study of marijuana use and head and neck squamous cell carcinomaModulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.Drug-induced hypothermia in stroke models: does it always protect?Targeting the endocannabinoid system in Alzheimer's disease.The endocannabinoid system: potential for reducing cardiometabolic riskThe endocannabinoid system as a target for the treatment of neurodegenerative disease.Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediatorPharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state.Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and diseaseCannabis use by individuals with multiple sclerosis: effects on specific immune parameters.The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ anAntiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis.Therapeutic potential of cannabinoid medicines.Cannabis smoking and respiratory health: consideration of the literature.Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent manner
P2860
Q24633122-0ACFC5A3-DCB6-4850-A183-DC9A944D20FBQ24633884-226EE66B-4033-4EF6-88E7-F9BEA735DE13Q24643922-CEA1A062-DCF6-4E7B-AB7F-1DDCBFD3971BQ24645478-40F15759-9787-4089-BF1A-5C9753B1495AQ24648473-076C01EB-5A58-4BCC-8DA3-1CD593F9A8F0Q24650098-33EBF771-F5CA-4B24-9C5C-89DBFEF83978Q24681482-C77F19D6-A8A6-46EC-8ED6-C76DDDFF925AQ26783325-5984A803-7BF7-4568-92B7-5E2FB73AA18AQ26852356-2912ED8F-5508-4052-A6F7-E0798030A3CCQ27312420-497A3B97-CCAD-4649-8587-6831AC4AE3DDQ28066215-1E6A0FF6-919F-45AD-9FFE-C8CF9A8AF295Q28072822-4EB89130-E392-496E-9D75-28C50183B74DQ28244460-E3BA3FC9-07B5-4D4B-B18C-924DAC77F5CEQ28277871-49F3A694-8A94-4B83-A56C-A78B2454A9A6Q28302804-838BA382-D0F6-424F-9DD9-E5416CA37370Q28568772-F56A01C2-1983-45D6-9E4F-FFD03890D4D7Q28572239-38190AC1-189D-4FE7-94ED-5F802F5BF5B0Q30300333-326C1530-F7A3-43B6-A49F-D76FB90014EEQ30477216-9239DFEE-253C-4AEE-82B6-FEFAC47A3217Q30491268-A6280F3F-97E3-44C5-B0D6-C507FAE244B1Q30495206-987725A4-E4ED-40B0-A453-B6F17D822617Q30506148-D52FD1F8-F46D-4C75-9B4B-20649B07489CQ33464957-11EC2140-E79E-4F98-B52A-87E5947F38F2Q33488512-FE444310-63BE-4A91-8B14-5DFF7DB68934Q33616287-3E320E5E-C721-4E3C-A591-ED6E5185CA02Q33793559-C2A21774-9FE1-4D71-9969-BAE240DAEE5CQ33844760-2D429214-A37C-44B7-84E3-94110C0DAA9BQ33930000-82CBC735-34DD-4325-91D0-1AE00BF5739DQ33999727-92735DE9-7836-4CF5-A7CC-7DF687E578ABQ34098196-1BFF6EBA-8D4A-4CC8-ACAA-1BB9E72F6794Q34116761-84EE1C4E-FDA7-41CC-A12B-CC2AD460AA62Q34125281-D4E52D75-97EB-4E0F-BD10-AF7D1F466F00Q34155467-CA57AD93-64FB-42E6-A180-0074BB0012B8Q34188446-FE7C5001-F33A-4516-9A09-179A71A286A0Q34219132-BBCD4FDA-4FF9-47B2-988C-28CBC4089430Q34267133-8598D67B-8BB5-4671-ACBB-317DA5F34E73Q34358271-C6AA5E66-7779-4C63-9E76-FD9E0490F45EQ34368715-CF750D2E-0866-4786-9E68-332FDCD7A00EQ34420153-8BABC104-10F3-487F-AFA0-96EDE0B4681AQ34422088-BED5F0DA-41B8-410E-9E44-10FE4AC18D6C
P2860
Cannabinoid-based drugs as anti-inflammatory therapeutics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cannabinoid-based drugs as anti-inflammatory therapeutics.
@ast
Cannabinoid-based drugs as anti-inflammatory therapeutics.
@en
type
label
Cannabinoid-based drugs as anti-inflammatory therapeutics.
@ast
Cannabinoid-based drugs as anti-inflammatory therapeutics.
@en
prefLabel
Cannabinoid-based drugs as anti-inflammatory therapeutics.
@ast
Cannabinoid-based drugs as anti-inflammatory therapeutics.
@en
P356
P1476
Cannabinoid-based drugs as anti-inflammatory therapeutics.
@en
P2093
Thomas W Klein
P2888
P304
P356
10.1038/NRI1602
P577
2005-05-01T00:00:00Z
P6179
1023677764